Surgery Partners, Inc. (NASDAQ:SGRY) Receives $36.56 Average Target Price from Brokerages

Shares of Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $36.56.

A number of analysts have weighed in on the stock. Bank of America initiated coverage on shares of Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. Royal Bank of Canada dropped their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. JPMorgan Chase & Co. lowered their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. UBS Group began coverage on Surgery Partners in a research report on Monday, October 14th. They set a “buy” rating and a $38.00 price target on the stock. Finally, KeyCorp initiated coverage on Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating for the company.

Read Our Latest Stock Report on SGRY

Hedge Funds Weigh In On Surgery Partners

Several hedge funds have recently modified their holdings of SGRY. FMR LLC boosted its holdings in Surgery Partners by 3.1% during the third quarter. FMR LLC now owns 18,311,867 shares of the company’s stock worth $590,375,000 after buying an additional 546,869 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of Surgery Partners by 27.5% during the 3rd quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock worth $177,235,000 after acquiring an additional 1,184,450 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Surgery Partners by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after acquiring an additional 42,897 shares during the last quarter. King Street Capital Management L.P. acquired a new stake in shares of Surgery Partners during the third quarter worth $46,748,000. Finally, Victory Capital Management Inc. raised its position in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after purchasing an additional 777,038 shares during the period.

Surgery Partners Stock Up 1.6 %

NASDAQ:SGRY opened at $25.70 on Friday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market capitalization of $3.27 billion, a price-to-earnings ratio of -53.54, a price-to-earnings-growth ratio of 17.66 and a beta of 2.60. Surgery Partners has a one year low of $19.50 and a one year high of $35.29. The stock has a 50-day simple moving average of $21.71 and a 200 day simple moving average of $27.00.

Surgery Partners (NASDAQ:SGRYGet Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.15 EPS. Sell-side analysts predict that Surgery Partners will post 0.71 EPS for the current fiscal year.

Surgery Partners Company Profile

(Get Free Report

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.